Navigation Links
Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Date:8/19/2007

We will work with the FDA to address its comments and pursue the approval of bifeprunox as soon as possible."

"The development of bifeprunox offers the possibility of a new treatment approach for patients where maintaining stability is challenged by the metabolic consequences frequently encountered with long-term therapy. We continue to support the development of the compound and the approach," adds Gary L. Stiles, M.D., Executive Vice President and Chief Medical Officer, Wyeth Pharmaceuticals.

Bifeprunox, a partial dopamine agonist designed to normalize levels of chemical activity in the brain, has been studied in approximately 2,650 patients with schizophrenia at more than 200 Phase 2 and 3 clinical trial sites in the United States and throughout the world.

About Solvay Pharmaceuticals, Inc.

Solvay Pharmaceuticals, Inc., of Marietta, Georgia, is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit http://www.solvaypharmaceuticals-us.com.

Solvay Pharmaceuticals is a research driven group of companies that constitute the global pharmaceutical business of the Solvay Group. The company seeks to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardiometabolic, influenza vaccines, gastroenterology, and men's and women's health. Its 2006 sales were EUR 2.6 billion and it employs approximately 10,000 people worldwide. For more information, visit http://www.solvaypharmaceuticals.com.

SOLVAY is an international chemical and pharmaceutical Group with headquarters in Brussels. It employs some 30,000 people in 50 countries. In 2006 its consolidated sales amounted to EUR 9.4 billion generated by its three activity sectors: Chemicals, Plastics and Pharmaceuticals. SOLVAY (Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on the Eur
'/>"/>

SOURCE Solvay Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
3. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
4. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data at Society Of Nuclear Medicine 2007 Annual Meeting
5. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
6. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
7. Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 2015 Un fournisseur mondial ... sont l,hypertension, le diabète et les troubles thyroïdiens ... de plateformes éducatives gratuites et d,une conférence majeure ... http://photos.prnewswire.com/prnh/20150630/227090 ) , Les ... ligne , Prendre en charge l,hypertension en ...
(Date:7/3/2015)... MUMBAI , July 4, 2015 ... the epidemics of hypertension, diabetes and thyroid disorders in ... free online educational platforms and a major conference dedicated ... Manage Diabetes Online , Manage ... - each developed and operated by EXCEMED ...
(Date:7/3/2015)... 3, 2015 According to ... Cardiac Rhythm Management Market ECG, Implantable Loop Recorder, ... Cardioverter Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P - ... global Cardiac Monitoring (CM) and Cardiac Rhythm Management ... Million by 2020 from $21,137.7 Million in 2015, ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4
... CORAL SPRINGS, Fla., Aug. 17 VirtuOx, Inc., ... in delivering home sleep testing solutions, today announced ... products and services company currently servicing the sleep-disordered ... in its portfolio, the VirtuOx Home Sleep Test ...
... Mass., Aug. 17 Block Engineering, a leading ... launch of a family of next-generation, revolutionary spectrometers ... Daniel Cavicchio, chairman of Block Engineering, commented, "This ... and it is the result of a multiyear ...
Cached Medicine Technology:VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions 2VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions 3Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers 2
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... Dori Friend opened registration for a new SEO training system called "Page ... guide for organic traffic generation has received glowing reviews from several well-known marketers. ...
(Date:7/3/2015)... , ... July 03, 2015 ... ... the sessions and speaker lineup for its 2015 Annual Conference , ... August 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. ...
(Date:7/3/2015)... ... ... Scientists at several top US cancer centers believe they now know why certain people ... read the complete story , just posted on the Surviving Mesothelioma website. , ... York University exposed mice with a mutation on the tumor suppressor gene called BAP1 ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, ... Dallas Rhinoplasty Symposium . To be held from March 4th - 6th, the 2016 ... the Westin Galleria Dallas. , Designed to take participants from the basic training and ...
(Date:7/3/2015)... Kan. (PRWEB) , ... July 03, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
Breaking Medicine News(10 mins):Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3
... small but significant number of patients suffered from complication ... ,About 4% were found to suffer from ... New York Times analysed the data supplied by the ... type of complications associated with the procedure is blood ...
... drug prescribed for the treatment of attention deficit hyperactivity ... New Zealand.// , But Drug agency Pharmac ... Ritalin manufacturer Novartis also advises that the drug ... parliamentary health secretary Christopher Pyne would ask the Therapeutic ...
... acidity of stomach contents backwashed into the esophagus allows ... throat discomfort// associated with the conventional wired monitor used ... while the new technology appears be better tolerated, no ... managing these patients, said David Mark, M.D., lead author ...
... Southwestern Medical Center is among 10 institutions selected to ... for critical trauma// and sudden cardiac arrest. ... U.S. and Canadian agencies to fund the $50 million ... centers in 10 North American regions. ,The ...
... turn down the immune system, making it more tolerant ... a transplanted heart//, researchers say. ,Human leukocyte ... gene family called major histocompatibility complex that provokes an ... the Medical College of Georgia. ,Like an ...
... that U.S. emergency medical care is stretched to its ... of the hour is to expand capacity//, address special ... patients arrive. ,A series of three reports ... (IOM) have pointed out that overcrowded hospital emergency departments ...
Cached Medicine News:Health News:New Reflux Disease Technology More Comfortable, Not More Effective 2Health News:New Reflux Disease Technology More Comfortable, Not More Effective 3Health News:Medical Center to Test Methods of Improving Cardiac Arrest, Trauma Survival 2Health News:Natural Approach to Immune Regulation May Help Transplant Patients 2Health News:Natural Approach to Immune Regulation May Help Transplant Patients 3Health News:US Emergency Rooms ill prepared for Disasters 2
... MedCath is the largest and most experienced ... networks in the United States. Mobile laboratories ... a daily basis, from one hospital to ... geographic area. Each mobile laboratory is fully ...
... VersaPulse PowerSuite holmium laser combines excellent ... precise, virtually bloodless procedures. It is ... and gall bladder stones of all ... surgical tool. Because its laser light ...
... Thanks to the progress and perfecting ... techniques have acquired a more strategic role ... technology in this sector has certainly contributed ... various urological pathologies that are becoming more ...
... The Acclaim 7000 Nd:YAG laser ... by offering cosmetic procedures such as ... facial veins, our Dermique LaserFACIAL for ... offers selectable parameters for customizing treatment ...
Medicine Products: